文献速递皮肤肿瘤

伴周围小球的黑素细胞病变风险适配监测:一项纵向队列研究

Risk-adapted monitoring of melanocytic lesions with peripheral globules: A longitudinal cohort study on melanoma risk stratification.
PubMed 文献 · J Am Acad Dermatol · 2026-08-06

该单中心双向队列研究纳入215例患者的1923个伴周围小球的黑素细胞病变,采用连续数字皮肤镜监测。随访中46.9%病变周围小球完全消退;持续存在、增多及色素增加、生长加快、个人黑素瘤史与不良组织病理学结局风险升高相关。

要点

  • 周围小球是动态表现,随访中可完全消退。
  • 小球持续存在或增多提示不良病理结局风险升高。
  • 色素增加、生长加快及个人黑素瘤史独立预测风险。

核心结论

  • 周围小球为动态而非静态表现,纵向行为可在基线形态之外改善风险分层。

研究设计与样本

  • 单中心双向队列研究,纳入215例患者的1923个伴周围小球的黑素细胞病变,进行连续数字皮肤镜监测。
  • 采用贝叶斯广义线性混合模型分析小球、生长速率和色素的纵向变化,含患者水平随机截距。

主要发现

  • 随访期间46.9%的病变周围小球完全消退。
  • 与小球消退相比,小球稳定者调整OR为3.91(95% CrI 1.32-12.21),小球增多者调整OR为4.18(95% CrI 1.33-13.93)。
  • 色素增加调整OR为6.33(95% CrI 2.39-18.21),生长速度每增加0.1 mm²/月调整OR为1.15(95% CrI 1.04-1.26),个人黑素瘤史调整OR为7.65(95% CrI 2.99-22.02),均与临床显著组织病理学终点独立相关,年龄无独立关联。

关键数值与推荐

  • 小球稳定调整OR 3.91(95% CrI 1.32-12.21),小球增多调整OR 4.18(95% CrI 1.33-13.93),均以小球消退为参照。
  • 色素增加调整OR 6.33(95% CrI 2.39-18.21),生长速度每0.1 mm²/月调整OR 1.15(95% CrI 1.04-1.26),个人黑素瘤史调整OR 7.65(95% CrI 2.99-22.02),均与临床显著组织病理学终点独立相关。

临床怎么用

  • 对伴周围小球的黑素细胞病变应进行连续数字皮肤镜随访,而非仅依据基线形态判断。
  • 随访中关注小球是否持续或增多、色素是否增加及生长速度,结合个人黑素瘤史进行风险分层。

局限性

  • 单中心设计。
  • 可能存在转诊偏倚。
  • 未切除病变缺乏组织病理学确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Peripheral globules are often considered a marker of benign horizontal growth in melanocytic nevi, but their significance during follow-up remains unclear. OBJECTIVE: To determine whether longitudinal evolution of peripheral globules and related lesion dynamics predict adverse histopathologic outcomes. METHODS: In this single-center ambispective cohort study, 1923 melanocytic lesions with peripheral globules from 215 patients underwent sequential digital dermoscopy. Longitudinal changes in globules, growth rate, and pigmentation were analyzed using a Bayesian generalized linear mixed model with patient-level random intercepts. RESULTS: During follow-up, 46.9% of lesions showed complete globule resolution. Compared with resolution, persistent globules were associated with increased risk, including stable globules (adjusted OR, 3.91; 95% CrI, 1.32-12.21) and increasing globules (adjusted OR, 4.18; 95% CrI, 1.33-13.93). Increasing pigmentation (adjusted OR, 6.33; 95% CrI, 2.39-18.21), faster growth (adjusted OR, 1.15 per 0.1 mm2/month; 95% CrI, 1.04-1.26), and personal history of melanoma (adjusted OR, 7.65; 95% CrI, 2.99-22.02) were independently associated with a clinically significant histopathologic endpoint, whereas age was not. LIMITATIONS: Single-center design, possible referral bias, and lack of histopathologic confirmation for non-excised lesions. CONCLUSION: Peripheral globules are dynamic rather than static findings, and longitudinal lesion behavior may improve risk stratification beyond baseline morphology alone.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Gündüz K, Erol Mart HM, Şimşek ÖF, et al. Risk-adapted monitoring of melanocytic lesions with peripheral globules: A longitudinal cohort study on melanoma risk stratification. J Am Acad Dermatol. 2026. PMID: 42562098. doi:10.1016/j.jaad.2026.08.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。